patent/PE-20091080-A1

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20091080-A1

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196
filingDate	2008-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_984aafeeac7dd9d640eaa3981e7bec48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3c0251b0560dde48bce3bac83af98b2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9966e2c660ac27d42659633ea9461589
publicationDate	2009-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	PE-20091080-A1
titleOfInvention	2- [3- (2,2-DIFLUORO-BENZO [1,3] DIOXOL-5-ILAMINO) -5- (2,6-DIMETHYL-PYRIDIN-4-IL) - [1,2,4] TRIAZOL- 1-IL] -N-ETHYL-ACETAMIDE AND ITS SALTS AS MODULATORS OF ALPHA 7 NICOTINE RECEPTORS
abstract	REFERRING TO THE COMPOUND 2- [3- (2,2-DIFLUORO-BENZO [1,3] DIOXOL-5-ILAMINO) -5- (2,6-DIMETHYL-PYRIDIN-4-IL) - [1,2,4 ] TRIAZOL-1-IL] -N-ETHYL-ACETAMIDE OF FORMULA (I), SALTS, HYDRATES AND SOLVATES OF THE SAME. IT ALSO REFERS TO A PREPARATION PROCEDURE AND A PHARMACEUTICAL COMPOSITION. SUCH COMPOUND IS A POSITIVE ALOSTERIC MODULATOR OF ACETYLCHOLINE ALPHA 7 NICOTINE RECEPTORS AND ARE USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE, LEWY'S BODY DEMENTIA, PARKINSON'S DISEASE, AMONG OTHERS
priorityDate	2007-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485969

Total number of triples: 28.